Technikos
Technikos is a London-based venture capital fund founded in 2006 that specializes in medical technology investments, operating with a small team of 1-10 employees. The firm raises capital from limited partners to deploy into medtech portfolio companies, though no portfolio or fund details are publicly disclosed.
- Company typePrivate
- Founded2006
- HeadquartersLondon, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Technikos does
Technikos is a London-based venture capital firm specializing in medical technology investments, founded in 2006. The firm operates with a small team of 1-10 employees and maintains an active web presence at technikos.co.uk, though the publicly accessible site only renders a verification/loading page and exposes no fund details, portfolio, team, or investment criteria.
The business model is consistent with a specialist venture GP: capital is raised from limited partners and deployed into medtech portfolio companies, with revenue generated through management fees on committed capital and carried interest on fund returns. As a niche sector fund rather than a generalist, Technikos's value proposition would rest on domain expertise, deal sourcing in the UK and European medtech ecosystem, and the principals' ability to underwrite regulated healthcare opportunities. No specific portfolio companies, fund vintages, AUM, check sizes, investment stages, exits, limited partners, or sector sub-theses are disclosed in the available source material.
The input data does not include information on management team composition, technology infrastructure, partnerships, regulatory standing, certifications, or recent strategic actions. Operating status is confirmed active based on the responsive domain, but absence of substantive public disclosures represents a material information gap for prospective investors, LPs, or acquisition counterparties evaluating the firm.
Technikos firmographics
Firmographics- Name
- Technikos
- Website
- https://technikos.co.uk
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Technikos is a London-based venture capital fund founded in 2006 that specializes in medical technology investments, operating with a small team of 1-10 employees. The firm raises capital from limited partners to deploy into medtech portfolio companies, though no portfolio or fund details are publicly disclosed.
- Ownership category
- akta.pro rank
Technikos industry classification
Industry- Product category
- Venture Capital / Healthcare Investment
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Corporate Fintech / Insurtech CVC (Financial-services-led CVC) (FSANAHAK)
Keywords
Where Technikos is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
Technikos business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales
Technikos product offering
Product offeringCore offering
Technikos is a London-based venture capital fund that invests in early-stage medical technology companies. Founded in 2006, the firm focuses its capital deployment on the medical technology sector. The fund operates with a small team of 1-10 employees.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Technology Venture Capital Fund A venture capital fund that provides equity capital and investment support to early-stage medical technology companies. Targeted at medical technology entrepreneurs and founders seeking institutional funding.
Companies that use Technikos
Customer profileIdeal customer profiles1 record
Technikos technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Technikos competitors and assessment
Company assessmentDirect peers
- Earlybird Health: Berlin-based venture capital firm with a dedicated health practice investing across biotech, medtech and digital health. Directly comparable as a European specialist healthcare venture capital firm.
- Advent Life Sciences: London-based venture capital firm investing in life sciences companies across therapeutics and medtech. Directly comparable as a London-headquartered, specialist life-sciences/medtech venture capital firm.
- Sofinnova Partners: Paris-based European venture capital firm focused on life sciences and medtech, investing across early- to late-stage healthcare opportunities. Directly comparable as a specialist European healthcare/medtech venture capital firm.
- Gilde Healthcare: Utrecht- and Cambridge-based venture and growth capital firm focused on healthcare and medtech in Europe and the US. Directly comparable as a specialist healthcare/medtech venture capital investor with European roots.
- NCL Technology Ventures: Specialist UK-based venture capital firm backing early-stage medical technology and life sciences companies. Comparable as a UK-based medtech-focused venture capital investor.
- Forbion: European life sciences venture capital firm with offices in the Netherlands and Germany, investing in biotech and medtech companies. Directly comparable as a European specialist healthcare venture capital investor.
- HealthTech Capital: US-based venture capital network investing specifically in healthtech and medical device companies. Directly comparable as a specialist medical technology venture capital investor.
Emerging players
- InnovaHealth Partners: Specialist medtech-focused growth equity firm investing in commercial-stage medical technology businesses. Comparable as a medtech-focused specialist investor, though oriented toward growth rather than venture-stage deals.
Broad incumbents
- M Ventures: Amsterdam-based corporate venture capital arm of Merck, with investments across life sciences and healthcare. Comparable as a healthcare-focused venture capital investor in Europe, though CVC rather than independent.
- Albion Capital: London-based investment manager with a life sciences / healthcare venture capital practice alongside other asset classes. Comparable as a London-based venture capital firm with healthcare exposure, though broader than a pure medtech specialist.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat2 records
Key risks4 records
Key highlights5 records
Customer concentration
Technikos social profiles
Digital presenceTechnikos financial estimates
Financial estimateRevenue estimate
Valuation estimate
Technikos leadership team
Management profileNumber of profiles
Technikos funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Technikos M&A and investment
M&A and investmentM&A
Investments3 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Technikos
What does Technikos do?
Technikos is a London-based venture capital fund that invests in early-stage medical technology companies. Founded in 2006, the firm focuses its capital deployment on the medical technology sector. The fund operates with a small team of 1-10 employees.
When was Technikos founded?
Technikos was founded in 2006. It employs 1 to 10 people.
Where is Technikos based?
Technikos is headquartered in London, United Kingdom, in the Europe region.
Who are Technikos's main competitors?
Direct peers on record are Earlybird Health, Advent Life Sciences, Sofinnova Partners, Gilde Healthcare, NCL Technology Ventures, Forbion and HealthTech Capital. InnovaHealth Partners is listed as an emerging player. Broad incumbents are M Ventures and Albion Capital.
Does Technikos have an API?
No public API is recorded for Technikos.
What industry is Technikos in?
Technikos's product category is Venture Capital / Healthcare Investment. Its primary akta.pro industry code is FSANAHAK, Corporate Fintech / Insurtech CVC (Financial-services-led CVC). Its NAICS code is 523940 and its SIC code is 6282.